ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

HYPR Hyperfine Inc

0.8039
-0.0233 (-2.82%)
Última actualización: 11:52:25
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Hyperfine Inc HYPR NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.0233 -2.82% 0.8039 11:52:25
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.85 0.8039 0.85 0.8272
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
29/4/202415:05BWHyperfine, Inc. to Announce First Quarter 2024 Financial..
23/4/202408:00BWHyperfine, Inc. Takes the Stage at ISMRM with Seventeen..
17/4/202408:00BWLeading Institutions Enroll First Alzheimer’s Patients..
21/3/202415:05GLOBEHyperfine, Inc. Reports Fourth Quarter and Full Year 2023..
21/3/202406:26IHMARKETNEWSU.S. Index Futures Rise as Fed’s Dovish Outlook Spurs..
12/3/202408:00BWHyperfine, Inc. Collaborates with King’s College London to..
07/3/202415:30BWHyperfine, Inc. to Announce Fourth Quarter and Full Year..
28/2/202415:30BWHyperfine, Inc. to Present at the Oppenheimer 34th Annual..
21/2/202408:00BWHyperfine, Inc. Announces Collaboration with Athletic Heart..
16/2/202415:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202407:00BWHyperfine, Inc. Celebrates Breadth of Swoop® System Data..
09/1/202408:00BWHyperfine, Inc. Launches AI-powered Brain Imaging Software..
23/11/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
20/11/202317:20EDGAR2Form 3/A - Initial statement of beneficial ownership of..
20/11/202308:00BWHyperfine, Inc. Announces Presentations on Clinical..
17/11/202318:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202308:00BWHyperfine, Inc. to Present at the Piper Sandler 35th Annual..
09/11/202315:58EDGAR2Form 8-K - Current report
09/11/202315:43EDGAR2Form S-3 - Registration statement under Securities Act of..
09/11/202315:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202315:10EDGAR2Form 8-K - Current report
09/11/202315:05GLOBEHyperfine, Inc. Reports Third Quarter 2023 Financial Results
02/11/202308:15BWObservational Study Finds That Hyperfine, Inc. Portable MR..
19/10/202315:05BWHyperfine, Inc. to Announce Third Quarter Financial Results..
10/10/202315:05BWHyperfine, Inc. Announces Promotions of Two Key Clinical..
09/10/202308:00BWHyperfine, Inc. Receives FDA Clearance for Updated..
03/10/202315:07EDGAR2Form 8-K - Current report
07/9/202315:05BWHyperfine, Inc. to Present at Gilmartin Group Emerging..
17/8/202315:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/8/202315:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202315:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202315:11EDGAR2Form 8-K - Current report
14/8/202315:05GLOBEHyperfine, Inc. Reports Second Quarter 2023 Financial..
09/8/202308:00BWEnrollment Completed for HOPE PMR Pediatric Hydrocephalus..
24/7/202315:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/7/202315:05BWHyperfine, Inc. to Announce Second Quarter Financial Results..
18/7/202315:19EDGAR2Form 8-K - Current report
18/7/202315:05BWHyperfine, Inc. Announces Promotion of Tom Teisseyre, Ph.D...
11/7/202308:00BWHyperfine, Inc. Launches Observational Study to Define New..
08/6/202308:00BWHyperfine, Inc. and the International Society for Magnetic..
18/5/202308:00BWHyperfine, Inc. Receives Grant for an Additional Three Years..
11/5/202315:05GLOBEHyperfine, Inc. Reports First Quarter 2023 Financial Results

Su Consulta Reciente

Delayed Upgrade Clock